The results are clear STEER demonstrates that semaglutide 2.4 mg cuts the risk of heart attack, stroke or death by 57% compared to tirzepatide, said Ludovic Helfgott, executive vice president and head of Product & Portfolio Strategy at Novo Nordisk
GLP-1 symptoms are not pleasant, not any more than living with a surgically reduced stomach
Whether you choose the abdomen, thigh, or upper arm, practicing proper injection technique and altering sites is key
The cream is dispensed in a pump mechanism, which allows for convenient and controlled application
PMID 18843658
Take a GLP-1specific history The consultation should document the agent, indication, starting date, dose-escalation schedule and any treatment interruptions